checkAd

     3617  0 Kommentare Global Allergic Rhinitis Drugs Market 2018-2028 - Visiongain Report

    LONDON, August 29, 2018 /PRNewswire/ --

    Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines

    The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.3% in the first half of the forecast period. The market is estimated at $12.2bn in 2017 and $14.3bn in 2022.

         (Photo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

    How this report will benefit you
    Read on to discover how you can exploit the future business opportunities emerging in this sector.

    In this brand new 256-page report you will receive 97 tables and 100 figures- all unavailable elsewhere.

    The 256-page report provides clear detailed insight into the global allergic rhinitis drugs market. Discover the key drivers and challenges affecting the market.

    By ordering and reading our brand-new report today you stay better informed and ready to act.

    Report Scope 

    • Global Allergic Rhinitis Drugs Market forecasts from 2018-2028

    • Along with revenue prediction for the overall world market for allergic rhinitis drugs, our investigation shows forecasts to 2028 for the following submarkets:
    • Intranasal Antihistamines
    • Intranasal Corticosteroids
    • Oral Antihistamines
    • Immunotherapy and Vaccines

    • How will leading allergic rhinitis drugs perform to 2028 at world level? Our study forecasts individual revenues of these 27 products:
    • Patanase
    • Astepro
    • Astelin
    • Dymista
    • Nasonex
    • Avamys
    • Veramyst
    • Flixonase
    • Rhinocort
    • Omnaris
    • Nasacort
    • Beconase
    • Qnasl
    • Zetonna
    • Allegra
    • Zyrtec
    • Claritin
    • Xyzal
    • Allelock
    • Clarinex
    • Ebastel
    • Talion
    • Staloral
    • Alutard SQ
    • Grazax
    • Ragwitek
    • Generic Azelastine

    • This report provides individual revenue forecasts to 2028 for these regional and national markets:
    • US
    • EU5 - Germany, UK, France, Italy and Spain
    China
    Japan
    India
    Russia
    Brazil
    • Rest of the World

    Each national market is further segmented by submarket. 

    • Our work provides analysis and sales forecast of the leading companies in the allergic rhinitis drugs market:
    • GlaxoSmithKline (GSK)
    Merck & Co
    • Sanofi
    • Johnson & Johnson
    • ALK-Abello
    • UCB
    • Kyowo Hako Kirin
    • Stallergenes Greer

    • This report discusses the trends and development in the allergic rhinitis pipeline

    • Our study discusses strengths, weaknesses, opportunities and threats as well as porter's five forces analysis of the global allergic rhinitis drugs market

    Visiongain's study is intended for anyone requiring commercial analyses for the global allergic rhinitis drugs market. You find data, trends and predictions.

    Buy our report today Global Allergic Rhinitis Drugs Market 2018-2028: Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines.

    To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website : https://www.visiongain.com/report/global-allergic-rhinitis-drugs-market-2018-2028/

    ActoGeniX
    Adamis Pharmaceuticals
    ALK- Abelló
    Allergy Medical UK
    Allergy Therapeutics
    Almirall
    Altana Pharma (Nycomed)
    Anergis
    Apotex
    AstraZeneca
    Atopix Therapeutics
    Barr Laboratories
    Bausch & Lomb
    Belcher Pharmaceuticals
    Biotech Tools 
    Catalent Pharma Solutions
    Celsus Therapeutics
    Dainippon Sumitomo
    DBV Technologies 
    Dr Reddy's Laboratories
    Eddingpharm
    Eleventa
    Genzyme (Sanofi)
    GlaxoSmithKline
    Greer Laboratories
    Hisamitsu Pharmaceutical Co
    Hoechst AG
    Human Genome Sciences
    Intas Pharmaceuticals
    Johnson & Johnson
    Keldman Healthcare
    Kyowa Hakko Kirin
    Leti Pharma (Laboratorios Leti)
    Lupin Pharmaceuticals
    Meda Pharma
    Medpointe Inc (Meda Pharma)
    Merck & Co
    Mitsubishi Tanabe Pharma
    Mylan
    Nippon Paper Group
    Novartis
    Omega Pharma
    Perrigo
    Pfizer
    ProStrakan (Kyowa Hakko Kirin)
    Reckitt Benckiser
    Roxane Laboratories (Boehringer Ingelheim)
    Sanofi 
    Schering-Plough (Merck)
    Shionogi & Co Ltd
    Stallergenes
    Sun Pharmaceuticals
    Sunovion Pharmaceuticals (Dainippon Sumitomo)
    Takeda
    Teva Pharmaceuticals
    Trimel Pharmaceuticals
    Ube Industries
    UCB
    ViiV Healthcare
    Wockhardt
    Ziarco Pharma

    To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Global Allergic Rhinitis Drugs Market 2018-2028 - Visiongain Report LONDON, August 29, 2018 /PRNewswire/ - Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.3% in the first half of the …